Fig. 3From: Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99Kaplan–Meyer curves of patients’ subsets with respect to OS (a-b) and TTP-TChemo (c-d). Baseline HER2ECD threshold values are 35 ng/ml in (a-b), and 15 ng/ml in (c-d)Back to article page